YD Bio Limited Ordinary Shares
YDES
Rank in Stocks
#27062
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company... Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Share Price
$4.88
Last synced: 2026-11-13
Market Cap
$16.64M
Change (1 day)
-6.15%
Change (1 year)
-60.16%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade YD Bio Limited Ordinary Shares (YDES)
Category
Healthcare
EPS for YD Bio Limited Ordinary Shares (YDES)
EPS as of June 2025 TTM: $-0.99
According to YD Bio Limited Ordinary Shares's latest financial reports, its current EPS (TTM) is $-0.99. At the end of 2025 the company had an EPS of $-0.12, an increase over its 2024 EPS of $-0.56.
EPS history for YD Bio Limited Ordinary Shares from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.99 | 725.00% |
| 2025 | $-0.12 | -78.57% |
| 2024 | $-0.56 | -280,100.00% |
| 2023 | 0.00 | -99.95% |
| 2022 | $0.41 | -30.51% |
| 2021 | $0.59 | -447.06% |
| 2020 | $-0.17 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -10.10% |
US
|
|
| $15.66 | -1,681.82% |
US
|
|
| $-7.07 | 614.14% |
US
|
|
| $-5.29 | 434.34% |
AU
|
|
| $12.73 | -1,386.08% |
BE
|
Questions about YD Bio Limited Ordinary Shares's earnings per share (EPS)
What is YD Bio Limited Ordinary Shares's earnings per share (EPS)?
YD Bio Limited Ordinary Shares's earnings per share (EPS) over the last twelve months is $-0.99, as of Jun 2025.
What was YD Bio Limited Ordinary Shares's earnings per share (EPS) in 2025?
In 2025, YD Bio Limited Ordinary Shares's earnings per share (EPS) was $-0.12, compared with $-0.56 in 2024.
How has YD Bio Limited Ordinary Shares's earnings per share (EPS) changed since 2020?
From 2020 to 2025, YD Bio Limited Ordinary Shares's earnings per share (EPS) was highest in 2021 ($0.59) and lowest in 2024 ($-0.56).
How does YD Bio Limited Ordinary Shares's earnings per share (EPS) compare with similar companies?
YD Bio Limited Ordinary Shares's earnings per share (EPS) ($-0.99) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.